Part 2 on the Study Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children (COVILLE2) (WHO)
- Conditions
- COVID19
- Interventions
- Diagnostic Test: RT-PCR SARS-Cov2Diagnostic Test: Sars-Cov2 serology
- Registration Number
- NCT04416893
- Lead Sponsor
- Centre Hospitalier Intercommunal Creteil
- Brief Summary
France and in particular the paris area was one of the countries most affected by the pandemic Covid19.
School closures and a generalized lockdown of the population were instituted in France from 17 March 2020 to 10 May 2020. Schools and nurseries have reopened partially since 11 May 2020. From 2 June, this reopening is more widespread. By combining the search for SARS-Cov2 viruses by PCR and micro-method serology we will be able to evaluate both the infection at a given time and also older contact with SARS-CoV2.
The temporal knowledge of the prevalence of SARS-Cov2 carriage and the serological status (IgM and IgG) after return to the community are crucial information to evaluate the speed of spread of the virus in children. This is the objective of COVILLE2, phase 2 of the COVILLE study.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
- Birth to 15 years old
- taking over the community (kindergarten, school, college, holiday centre, etc.) for at least 1 week
- refusal to participate
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Children under 15 years of age in a community Sars-Cov2 serology Children under 15 years of age in a community : kindergarten, school, college, holiday center, etc. Children under 15 years of age in a community RT-PCR SARS-Cov2 Children under 15 years of age in a community : kindergarten, school, college, holiday center, etc.
- Primary Outcome Measures
Name Time Method Proportion of asymptomatic children or children with mild respiratory symptoms At inclusion Proportion of asymptomatic children or children with mild respiratory symptoms (mildly-symptomatic children) with a positive SARS-Cov2 Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) on rhino pharyngeal swab or/and IgM/IgG positive serology in Paris area
- Secondary Outcome Measures
Name Time Method Cov2-SARS cases by age At inclusion Viral load At inclusion The viral load of children with SARS-Cov2 positive Reverse Transcriptase Polymerase Chain Reaction depending on the symptoms and the age of the patients
Cov2-SARS cases by symptoms At inclusion Presence of anti-SARS-CoV-2 antibodies (IgM and IgG) by the rapid serological test At inclusion